1–3 of 3 results for ABCA4
Oral Gildeuretinol Slows Disease Progression in Early Stargardt Disease: Updates From the TEASE-3 Study
Kenneth C Fan, MD, MBA
Annual Meeting Talks
2025
Oral Gildeuretinol Acetate 14 mg Capsules Stalled Stargardt Disease Progression: Updates in the TEASE-3 Study
Michael Gorin, MD, PhD
2024
Qualitative Analysis of Imaging Features and Predictors of Visual Acuity in ABCA4- and PRPH2-Related Disease